Chemed Co. (NYSE:CHE) Shares Sold by Amundi

Amundi reduced its stake in shares of Chemed Co. (NYSE:CHE - Free Report) by 23.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,790 shares of the company's stock after selling 11,340 shares during the quarter. Amundi owned about 0.25% of Chemed worth $20,105,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Raymond James Financial Inc. acquired a new stake in shares of Chemed during the fourth quarter worth about $42,023,000. Aigen Investment Management LP raised its stake in shares of Chemed by 300.4% during the fourth quarter. Aigen Investment Management LP now owns 2,002 shares of the company's stock worth $1,061,000 after purchasing an additional 1,502 shares during the last quarter. M&T Bank Corp lifted its holdings in shares of Chemed by 14.4% during the fourth quarter. M&T Bank Corp now owns 964 shares of the company's stock worth $511,000 after purchasing an additional 121 shares during the period. Charles Schwab Investment Management Inc. grew its position in Chemed by 10.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 136,182 shares of the company's stock valued at $72,149,000 after buying an additional 13,394 shares during the last quarter. Finally, SRS Capital Advisors Inc. increased its stake in Chemed by 39.2% in the 4th quarter. SRS Capital Advisors Inc. now owns 135 shares of the company's stock valued at $72,000 after buying an additional 38 shares during the period. 95.85% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the completion of the sale, the chief executive officer now directly owns 102,679 shares in the company, valued at $60,957,441.93. The trade was a 1.91 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, VP Brian C. Judkins acquired 145 shares of Chemed stock in a transaction that occurred on Monday, December 30th. The shares were purchased at an average cost of $519.50 per share, for a total transaction of $75,327.50. Following the purchase, the vice president now directly owns 1,678 shares of the company's stock, valued at approximately $871,721. This trade represents a 9.46 % increase in their position. The disclosure for this purchase can be found here. Insiders own 3.32% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

CHE has been the subject of a number of recent analyst reports. StockNews.com upgraded shares of Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. Royal Bank of Canada lifted their price target on shares of Chemed from $633.00 to $667.00 and gave the company an "outperform" rating in a research report on Friday.

Chemed Trading Up 1.7 %

Shares of CHE stock traded up $10.41 during mid-day trading on Monday, reaching $608.63. The stock had a trading volume of 101,238 shares, compared to its average volume of 87,700. The company has a market cap of $8.91 billion, a P/E ratio of 30.75, a price-to-earnings-growth ratio of 2.15 and a beta of 0.43. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $653.75. The business has a 50-day simple moving average of $560.28 and a 200 day simple moving average of $564.74.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.33%. The ex-dividend date of this dividend was Monday, February 24th. Chemed's payout ratio is currently 10.05%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.